Suppr超能文献

Variation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom.

作者信息

Parkes Julie, Roderick Paul, Bennett-Lloyd Bethan, Rosenberg William

机构信息

Public Health Sciences & Medical Statistics (805) Level C, University of Southampton, Southampton General Hospital, Tremona Road, Southampton UK.

出版信息

BMC Public Health. 2006 Jan 10;6:3. doi: 10.1186/1471-2458-6-3.

Abstract

BACKGROUND

Chronic hepatitis C infection (CHC) is a major healthcare problem. Effective anti-viral therapy is available. To maximise population effectiveness, co-ordinated services for detection and management of patients with CHC are required. There is a need to determine patterns of healthcare delivery to plan improvements. A study was conducted to determine workload, configuration and care processes of current UK services available to manage patients with CHC.

METHODS

A cross-sectional questionnaire survey of consultant members of British Association for the Study of the Liver (n = 53), Infectious Disease consultants (n = 43), and a 1 in 5 sample of Genito-Urinary Medicine (n = 48) and gastroenterologists (n = 200).

RESULTS

Response rate was 70%. 40% of respondents provided a comprehensive service (included treatment and follow-up): speciality of clinical leads identified as Hepatology (37%); Gastroenterology (47%); and Infectious Disease (16%). The estimated number of patients managed by respondents was about 23,000 with an upward trend over the previous 3 years. There was variation between comprehensive service providers, including unit size, eligibility criteria for treatment, and drug regimes. Key barriers to quality of care identified were staffing capacity, funding of treatment and patient non-attendance. Most English strategic health authorities had at least one comprehensive service provider.

CONCLUSION

There was significant variation in all aspects of the patient pathway which may contribute to inequity of health care provision. Services need to be expanded to form geographical clinical networks, and properly resourced to ensure greater uptake and more equitable delivery of services if the future burden of chronic liver disease is to be reduced.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be64/1382203/cdccedb947b9/1471-2458-6-3-1.jpg

相似文献

3
Critical Care Network in the State of Qatar.
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
4
6
Provision, uptake and cost of cardiac rehabilitation programmes: improving services to under-represented groups.
Health Technol Assess. 2004 Oct;8(41):iii-iv, ix-x, 1-152. doi: 10.3310/hta8410.
7
Current practice of ototoxicity management across the United Kingdom (UK).
Int J Audiol. 2018 Sep;57(sup4):S76-S88. doi: 10.1080/14992027.2018.1460495. Epub 2018 Apr 20.
8
The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):208-16. doi: 10.1161/CIRCOUTCOMES.111.000058. Epub 2013 Mar 12.

引用本文的文献

2
Impact of HIV and chronic kidney disease comorbidities on hepatitis C treatment choices, drug-drug interactions and hepatitis C cure.
Int J Clin Pharm. 2020 Apr;42(2):515-526. doi: 10.1007/s11096-020-00994-6. Epub 2020 Feb 25.
5
Access to treatment for Hepatitis C among injection drug users: results from the cross-sectional HOPE IV study.
Int J Equity Health. 2017 Jun 14;16(1):101. doi: 10.1186/s12939-017-0601-3.
7
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England.
J Viral Hepat. 2016 Aug;23(8):631-43. doi: 10.1111/jvh.12529. Epub 2016 Mar 29.

本文引用的文献

2
Diagnosis, management, and treatment of hepatitis C.
Hepatology. 2004 Apr;39(4):1147-71. doi: 10.1002/hep.20119.
4
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
Int J Epidemiol. 2003 Oct;32(5):717-24. doi: 10.1093/ije/dyg101.
7
Fibrosis and disease progression in hepatitis C.
Hepatology. 2002 Nov;36(5 Suppl 1):S47-56. doi: 10.1053/jhep.2002.36993.
8
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
N Engl J Med. 2002 Sep 26;347(13):975-82. doi: 10.1056/NEJMoa020047.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验